Connection

Thomas Keane to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Thomas Keane has written about Aged, 80 and over.
Thomas Keane
Connection Strength
0.214
Aged, 80 and over
  1. Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer. Urology. 2008 Jun; 71(6):1177-80.
    View in: PubMed
    Score: 0.039
  2. Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data. J Urol. 2021 02; 205(2):554-560.
    View in: PubMed
    Score: 0.024
  3. The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data. J Urol. 2020 Apr; 203(4):743-750.
    View in: PubMed
    Score: 0.022
  4. Six Weeks of Fluoroquinolone Antibiotic Therapy for Patients With Elevated Serum Prostate-specific Antigen Is Not Clinically Beneficial: A Randomized Controlled Clinical Trial. Urology. 2016 Apr; 90:32-7.
    View in: PubMed
    Score: 0.017
  5. Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer. Eur Urol. 2015 Feb; 67(2):334-41.
    View in: PubMed
    Score: 0.015
  6. A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer. Am J Clin Oncol. 2014 Apr; 37(2):188-93.
    View in: PubMed
    Score: 0.015
  7. Phase I trial of weekly docetaxel, total androgen blockade, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma. Clin Genitourin Cancer. 2014 Apr; 12(2):80-6.
    View in: PubMed
    Score: 0.015
  8. Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1?year after diagnosis: an economic perspective. Support Care Cancer. 2013 Dec; 21(12):3461-9.
    View in: PubMed
    Score: 0.014
  9. Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer. Clin Nucl Med. 2011 Oct; 36(10):872-8.
    View in: PubMed
    Score: 0.013
  10. Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int. 2011 Sep; 108(6):851-6; discussion 856-7.
    View in: PubMed
    Score: 0.012
  11. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011 Apr; 59(4):543-52.
    View in: PubMed
    Score: 0.012
  12. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int. 2005 Dec; 96(9):1280-5.
    View in: PubMed
    Score: 0.008
  13. Outcome following radiotherapy in verrucous carcinoma of the larynx. Int J Radiat Oncol Biol Phys. 1995 Jun 15; 32(3):611-7.
    View in: PubMed
    Score: 0.004
  14. Gastric cancer: the case for a more selective policy in surgical management. J R Coll Surg Edinb. 1993 Aug; 38(4):208-12.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.